Literature DB >> 27885760

Haploidentical hematopoietic stem cell transplantation for a case with X-linked chronic granulomatous disease.

Ling Zhou1,2, Lu-Jia Dong2, Zhi-Yong Gao2, Xin-Jian Yu2, Dao-Pei Lu1,2.   

Abstract

CGD is a rare primary immunodeficiency with high mortality rates when treated conventionally, especially for the X-chromosome-linked form. HSCT is the only curative therapy for CGD; however, haploidentical transplantation in CGD is rare. Here, we report a case of X-linked CGD treated successfully by haploidentical HSCT. The patient showed a positive result with full donor chimerism, good quality of life, and the absence of recurrent infectious diseases at follow-up (68 months). Thus, haploidentical HSCT may serve as an acceptable treatment approach for patients who have CGD, but no HLA-matched related or unrelated donor.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  X-linked chronic granulomatous disease; haploidentical; myeloablative conditioning

Mesh:

Substances:

Year:  2016        PMID: 27885760     DOI: 10.1111/petr.12861

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  2 in total

1.  Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.

Authors:  Mark Parta; Dianne Hilligoss; Corin Kelly; Nana Kwatemaa; Narda Theobald; Christa S Zerbe; Steven M Holland; Harry L Malech; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2020-04-20       Impact factor: 8.317

Review 2.  A Review of Chronic Granulomatous Disease.

Authors:  Danielle E Arnold; Jennifer R Heimall
Journal:  Adv Ther       Date:  2017-11-22       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.